GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: shortage stopped being a problem at week 71 — 29 comments in the full submission. View in context.
619
c/glp1aus·submitted 2 years ago by u/chidi_abubakar

small win: shortage stopped being a problem at week 71

Questionbranch of 7 comments

Quick one. Canada here. Australia works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 19 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 29 comments →

This branch

7 comments, started 2 years ago
u/marta_ilunga48 points·2 years ago

Mechanistically the bit that matters is shortage. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/rafael_ostergaard12 points·2 years ago

the regulatory PBS is the blocker

replysharereportpermalink
u/copay_card_cc3 points·2 years ago

AU and NZ are different systems, say which

replysharereportpermalink
[deleted]1 point·2 years ago

[deleted]

replysharereportpermalink
u/marta_ilunga8 points·2 years ago

TGA shortage notices are temporary

replysharereportpermalink
u/zeynep_ndiaye9 points·2 years ago

Strongly agree. AU and NZ differ.

replysharereportpermalink
u/runa_pires11 points·2 years ago

the the UK versus the UK distinction is real

replysharereportpermalink

← back to the whole thread

About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.